Friday - March 13, 2026

Positron Emission Tomography Market to Surpass USD 3.12 Billion by 2032, Growing at a CAGR of 6.23% Driven by Rising Chronic Disease Burden and Advanced Imaging Technologies | DelveInsight

Positron Emission Tomography Market Positron emission tomography companies include General Electric Company, Bruker Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, Positron Corporation, Shimadzu Corp., RefleXion, CMR Naviscan Corporation, Segami Corporation, Neusoft Medical Systems Co., Ltd., Mediso … Continue reading

Peripheral T-Cell Lymphoma Market Outlook 2034: US Market Surpasses USD 500 Million in 2023 with 12,600+ Cases Driving Demand for Next-Gen Treatments, analyses DelveInsight

Peripheral T-Cell Lymphoma Market Leading companies developing Peripheral T-cell Lymphoma treatments include Eisai, Celgene Corporation, HUYA Bioscience International/Quintiles, Verastem, BeiGene, Merck Sharp & Dohme Corp, Solasia Pharma, Aileron Therapeutics, Incyte, Novartis, among others. In 2023, the US led the Peripheral … Continue reading

Psoriatic Arthritis Market Outlook 2034: 30+ Key Companies, 20+ Emerging Drugs, and Expanding 7MM Epidemiology Insights | DelveInsight

Psoriatic Arthritis Market Psoriatic Arthritis companies are UCB Biopharma, Sun Pharmaceutical Industries Limited, BMS, Affibody AB, Janssen Biotech, Amgen, Eli Lilly and Company, Teva Pharma, Boehringer Ingelheim, AbbVie, Roche, Ampio Pharmaceuticals, Antares Pharma, Currax Pharmaceuticals, GlaxoSmithKline, Bayer, Sanofi, Astrazeneca, Johnson … Continue reading

Psychosis in Parkinson’s and Alzheimer’s Disease Market to Surpass USD 1.29 Billion by 2034 Across the 7MM, 6.9 Million Psychosis Cases and 5+ Emerging Therapies Driving Growth, analyses DelveInsight

Psychosis in Parkinson’s and Alzheimer’s Disease Market Key Psychosis in Parkinson’s and Alzheimer’s Disease Companies are Karuna Therapeutics, Sunovion Pharmaceuticals, Intra-Cellular Therapies, Acadia Pharmaceuticals, and others DelveInsight has launched a new report on “Psychosis in Parkinson’s and Alzheimer’s Disease – … Continue reading

Advanced Melanoma Clinical Trial Pipeline Expands as 55+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Advanced Melanoma Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the Advanced Melanoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading

Advanced Liver Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s “Advanced Liver Cancer Pipeline Insights 2026” Report provides comprehensive insights about 50+ companies and 52+ pipeline drugs in the advanced liver cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Advanced Hepatocellular Carcinoma Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight “Advanced Hepatocellular Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Hepatocellular Carcinoma pipeline landscape. It covers the Advanced Hepatocellular Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Advanced Gastric Carcinoma Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Advanced Gastric Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Gastric Carcinoma pipeline landscape. It covers the Advanced Gastric Carcinoma pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading